Company / Operating Cash Flow
ATOSSA THERAPEUTICS, INC. Operating Cash Flow History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$14.0M
FY2016
5-year range
-$14.0M / -$3.5M
FY2012-FY2016
Trend
-32.2%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has declined for 4 consecutive years, from -$3M in FY2012 to -$14M in FY2016.
Based on SEC 10-K filings.
-$14M in FY2016.
Declined from -$9M to -$14M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ATOSSA THERAPEUTICS, INC.'s operating cash flow has declined for 4 consecutive years.
- In FY2016, operating cash flow decreased 32.2% year-over-year.
- Peak operating cash flow was recorded in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | -$14.0M | -32.2% |
| FY2015 | -$10.6M | -19.5% |
| FY2014 | -$8.8M | -126.4% |
| FY2013 | -$3.9M | -11.7% |
| FY2012 | -$3.5M | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026